COMMUNIQUÉS West-GlobeNewswire

-
ATW Tech Completes a Private Placement of Units of $423,640
22/12/2017 - 22:00 -
ATW Tech complète un placement privé d’unités de 423 640 $
22/12/2017 - 22:00 -
Abattis Provides Company Update and Comments on LOI Regarding Green Tree Therapeutics
22/12/2017 - 21:26 -
PSI Raises Record Amount for Charity at its 20th Annual Golf Tournament
22/12/2017 - 20:45 -
NEOVACS : AVIS AUX PORTEURS DE BSA NEOVACS 2017 (FR0013275971) MODALITES D'AJUSTEMENT LEGAL ET CONTRACTUEL
22/12/2017 - 19:14 -
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
22/12/2017 - 18:17 -
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
22/12/2017 - 18:15 -
Cannabis Wheaton Income Corp. Announces Signing of Definitive Agreement With Streaming Partner CannTx Life Sciences Inc.
22/12/2017 - 18:00 -
Biotricity Closes a Registered Direct Financing and Paves the Way for Bioflux Launch
22/12/2017 - 17:57 -
Cannabis Wheaton Income Corp. Announces Private Placement of Convertible Debenture Units and Conversion of Prior Convertible Debenture Units
22/12/2017 - 16:04 -
American Health Council Appoints Tamra Ward MSN, ARNP, NP-C, CHFN, CCTC to its Nursing Board
22/12/2017 - 15:46 -
BioCorRx Recovery Program Used in Lieu of Conviction in Ohio
22/12/2017 - 15:41 -
Canada House Wellness Group’s Intended Uses of Funds from Recently Closed $8.6 Million Convertible Debenture Unit Financing
22/12/2017 - 15:39 -
Imaging3’s New CEO Provides end-of-year Company Update
22/12/2017 - 15:30 -
Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 36th Annual Healthcare Conference on January 10, 2018
22/12/2017 - 15:05 -
Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Share Repurchase Program
22/12/2017 - 15:00 -
GBT Appoints Wendy L. Yarno to Board of Directors
22/12/2017 - 15:00 -
Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics
22/12/2017 - 14:37 -
Tauriga Sciences, Inc. Extinguishes its Largest Remaining Balance Sheet Liability for One Time Cash Payment of $15,000 and One Time Issuance of 5,000,000 Restricted Shares; Liability Dated Back to the Years 2010/2011 and Totaled $177,883.71
22/12/2017 - 14:30
Pages